Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 14, 2017; 23(22): 4016-4038
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.4016
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.4016
Figure 2 Expression of fluorescence, protein, and mRNA of HO-1 in HO-1 modified BMMSCs.
A: Bright field microscopy of HO-1 modified BMMSCs; B: Fluorescent microscopy of HO-1 modified BMMSCs (The positive expression rate of GFP exceeded 85 %); C: Expression of HO-1 protein in HO-1 modified BMMSCs and native BMMSCs; D: The expression of HO-1 protein in HO-1 modified BMMSCs (0.903 ± 0.072) was significantly higher than that in native BMMSCs (0.348 ± 0.065; P < 0.05); E: The relative expression of HO-1 mRNA in HO-1 modified BMMSCs (8.89 ± 0.40) was 7.89 times higher than that in native BMMSCs (1.00 ± 0.24; P < 0.05). BMMSCs: Bone marrow mesenchymal stem cells; HO-1: Heme oxygenase-1.
- Citation: Yin ML, Song HL, Yang Y, Zheng WP, Liu T, Shen ZY. Effect of CXCR3/HO-1 genes modified bone marrow mesenchymal stem cells on small bowel transplant rejection. World J Gastroenterol 2017; 23(22): 4016-4038
- URL: https://www.wjgnet.com/1007-9327/full/v23/i22/4016.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i22.4016